Table 1.
Risk Factors Associated With Increased Morbidity and Mortality in Patients With Polycythemia Vera
| Risk Factors |
|---|
| For thrombosis |
| Age > 60 years |
| Previous history of thrombosis |
| Leukocytosis39–42* |
| Increased JAK2 V617F allele burden6,43–45* |
| High-risk gene expression profile46* |
| For transformation to myelofibrosis or secondary acute myeloid leukemia |
| Older age47 |
| Longer disease duration48 |
| Leukocytosis41 |
| Exposure to phosphorus-32, pipobroman, or chlorambucil7,48 |
| Risk factor associated with decreased survival |
| Older age7 |
| Leukocytosis7 |
| History of venous thrombosis7 |
| Abnormal karyotype7 |
Emerging or controversial risk factor.